Alpha Tau Medical Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, filed on May 13, 2025, by Alpha Tau Medical Ltd., a foreign private issuer, serves to furnish documents related to the Company's Annual General Meeting of Shareholders. The meeting is scheduled for June 17, 2025, at the Company's headquarters in Jerusalem, Israel.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding shareholder governance and does not contain financial performance data.
Material Changes
No material changes to financial operations or business conditions are reported in this document. The filing focuses solely on the administrative details of the upcoming shareholder meeting.
Guidance, Outlook, and Risks
The document contains no management commentary, financial guidance, or discussion of risks and contingencies. It includes a notice and proxy statement (Exhibit 99.1) and a proxy card (Exhibit 99.2) detailing proposals to be voted upon and voting procedures.
Key Facts for Investors
- Meeting Date: June 17, 2025, at 3:00 p.m. Israel time.
- Location: 5 Kiryat Hamada St., Jerusalem, Israel.
- Documents Furnished: Notice and proxy statement (Exhibit 99.1) and proxy card (Exhibit 99.2).
- Signatory: Uzi Sofer, Chief Executive Officer.
- Financial Data: None included in this specific filing.